Literature DB >> 12707949

Genetics of recurrent early-onset depression (GenRED): design and preliminary clinical characteristics of a repository sample for genetic linkage studies.

Douglas F Levinson1, George S Zubenko, Raymond R Crowe, Raymond J DePaulo, William S Scheftner, Myrna M Weissman, Peter Holmans, Wendy N Zubenko, Sandra Boutelle, Kathleen Murphy-Eberenz, Dean MacKinnon, Melvin G McInnis, Diana H Marta, Philip Adams, Stephanie Sassoon, James A Knowles, Jo Thomas, Jennifer Chellis.   

Abstract

This is an initial report on a six-site collaborative project, Genetics of Recurrent Early-Onset Depression (GenRED). This is a study of a large sample of families with recurrent major depressive disorder (DSM-IV) beginning by the age 30 in probands or 40 in relatives. Evidence suggests that early onset and recurrence of depressive episodes predict substantially increased risk of depression in first-degree relatives compared with the general population, suggesting that susceptibility genes might be mapped with this phenotype. The projected sample of 800-1,000 affected sibling pairs (ASPs) and other relatives will be studied using genome scan methods. Biological materials and blinded clinical data will be made available through the NIMH cell repository program. The sample should have good-to-excellent power to detect a locus associated with a 24% or greater population-wide increase in risk to siblings. We describe 838 affected individuals from the first 305 families containing 434 independent ASPs, or 613 ASPs counting all possible pairs. The mean age at the onset was 18.5 years, with a mean of 7.3 episodes and longest episode of 655 days. Almost all subjects had experienced at least 4 weeks of depression with five or more additional symptom criteria. Frequencies of symptoms and psychiatric and medical comorbid are provided. Substance use was more common in males, and panic disorder in females. Within pairs of affected siblings, correlations were significant for age at onset, substance abuse/dependence, panic disorder, obsessive-compulsive disorder and nicotine initiation and persistence. We replicated previously reported associations among comorbid panic disorder and social phobia, chronicity of depression and suicidal behavior. This suggests comparability of our cases to those in earlier large family studies. This dataset should prove useful for genetic studies of a highly familial form of major depressive disorder. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12707949     DOI: 10.1002/ajmg.b.20009

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  30 in total

Review 1.  Translational epidemiology in psychiatry: linking population to clinical and basic sciences.

Authors:  Myrna M Weissman; Alan S Brown; Ardesheer Talati
Journal:  Arch Gen Psychiatry       Date:  2011-06

Review 2.  The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse.

Authors:  Jacob P R Jacobsen; Ivan O Medvedev; Marc G Caron
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

3.  Case-control association study of TGOLN2 in attempted suicide.

Authors:  Pamela B Mahon; Adrian M Stütz; Fayaz Seifuddin; Yuqing Huo; Fernando S Goes; Dubravka Jancic; Jennifer T Judy; J Raymond Depaulo; Elliot S Gershon; Francis J McMahon; Peter P Zandi; James B Potash; Virginia L Willour
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-07       Impact factor: 3.568

Review 4.  The genetics of major depression: moving beyond the monoamine hypothesis.

Authors:  Stanley I Shyn; Steven P Hamilton
Journal:  Psychiatr Clin North Am       Date:  2010-03

5.  Using the high-risk family design to identify biomarkers for major depression.

Authors:  Ardesheer Talati; Myrna M Weissman; Steven P Hamilton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

6.  High-throughput sequencing of the synaptome in major depressive disorder.

Authors:  M Pirooznia; T Wang; D Avramopoulos; J B Potash; P P Zandi; F S Goes
Journal:  Mol Psychiatry       Date:  2015-07-28       Impact factor: 15.992

7.  Pupillary reactivity to negative stimuli prospectively predicts recurrence of major depressive disorder in women.

Authors:  Anastacia Y Kudinova; Katie L Burkhouse; Greg Siegle; Max Owens; Mary L Woody; Brandon E Gibb
Journal:  Psychophysiology       Date:  2016-09-27       Impact factor: 4.016

8.  Premenstrual mood symptoms: study of familiality and personality correlates in mood disorder pedigrees.

Authors:  Jennifer L Payne; Sarah R Klein; Rachel B Zamoiski; Peter P Zandi; Oscar J Bienvenu; Dean F Mackinnon; Francis M Mondimore; Barbara Schweizer; Karen L Swartz; Raymond P Crowe; William A Scheftner; Myrna M Weissman; Douglas F Levinson; J Raymond DePaulo; James B Potash
Journal:  Arch Womens Ment Health       Date:  2009-01-10       Impact factor: 3.633

9.  Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.

Authors:  S I Shyn; J Shi; J B Kraft; J B Potash; J A Knowles; M M Weissman; H A Garriock; J S Yokoyama; P J McGrath; E J Peters; W A Scheftner; W Coryell; W B Lawson; D Jancic; P V Gejman; A R Sanders; P Holmans; S L Slager; D F Levinson; S P Hamilton
Journal:  Mol Psychiatry       Date:  2009-12-29       Impact factor: 15.992

10.  Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo.

Authors:  P F Sullivan; E J C de Geus; G Willemsen; M R James; J H Smit; T Zandbelt; V Arolt; B T Baune; D Blackwood; S Cichon; W L Coventry; K Domschke; A Farmer; M Fava; S D Gordon; Q He; A C Heath; P Heutink; F Holsboer; W J Hoogendijk; J J Hottenga; Y Hu; M Kohli; D Lin; S Lucae; D J Macintyre; W Maier; K A McGhee; P McGuffin; G W Montgomery; W J Muir; W A Nolen; M M Nöthen; R H Perlis; K Pirlo; D Posthuma; M Rietschel; P Rizzu; A Schosser; A B Smit; J W Smoller; J-Y Tzeng; R van Dyck; M Verhage; F G Zitman; N G Martin; N R Wray; D I Boomsma; B W J H Penninx
Journal:  Mol Psychiatry       Date:  2008-12-09       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.